Reassess labs and document changes through photos
GLP-1 medications may offer meaningful benefits for some people living with MS by: At the same time, its important to be clear: When used thoughtfully, they may be one piece of a broader approach to health alongside MS medications, rehabilitation, nutrition, movement, mental health support, and community
Semaglutide was originally designed as drug for diabetes and sold as Ozempic, but was approved for weight loss by the FDA in 2021 under the name Wegovy
Now, on the flip side, compliance is still a problem
Exendin-4 versus human GLP-1 analogue structural pharmacology The clustering of immune-mediated adverse pulmonary eventsanaphylaxis, angioedema, bronchospasm, eosinophilic pneumoniapredominantly with exendin-4-based agents (exenatide, lixisenatide) rather than human GLP-1 analogues (liraglutide, semaglutide, dulaglutide) is neither coincidental nor mechanistically obscure
908 Kuang, H